Physician profile
Ted H Brady
NPI 1831150515
$6,408.04
in general payments reported to CMS, 2019-2025
26 companies · $1,173 in 2025
The $1,173 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $859 · 2020: $438 · 2021: $568 · 2022: $1,023 · 2023: $1,097 · 2024: $1,251 · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,520.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,196.19 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $833.78 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Genzyme Corporation | $605.53 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $568.10 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $494.06 | 2019-2025 | Dupixent |
| Amgen INC. | $237.16 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $231.33 | 2019-2025 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $189.95 | 2019-2020 | |
| Mylan Specialty L.P. | $144.90 | 2019-2023 | Yupelri |
| United Therapeutics Corporation | $136.41 | 2019-2024 | Tyvaso |
| Paratek Pharmaceuticals, INC. | $106.82 | 2019-2024 | Nuzyra |
| Actelion Pharmaceuticals US, INC. | $79.34 | 2019-2023 | Uptravi, Opsumit |
| Vifor Pharma, INC. | $77.65 | 2024-2025 | Veltassa, Zemaira |
| Novartis Pharmaceuticals Corporation | $59.41 | 2019-2022 | |
| Verona Pharma, INC. | $57.51 | 2025 | Ohtuvayre |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $56.56 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Genentech USA, INC. | $48.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.91 | 2021-2022 | |
| Philips North America LLC | $41.67 | 2023-2024 | (Ak6) Vest Therapy |
| Baxter Healthcare | $38.19 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $36.35 | 2022-2025 | Winrevair |
| Ethicon INC. | $35.11 | 2021 | |
| Circassia INC. | $31.99 | 2019 | |
| Insmed, INC. | $22.74 | 2024 | Arikayce |
| Viatris Specialty LLC | $18.01 | 2025 | Yupelri |
| Gilead Sciences, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.